DR. WILLIAM N. BICHAI M.D. NPI 1548349004

NPI Details

DR. William N. Bichai, M.D. is a nephrology internal medicine in Bakersfield, CA with 23 years of experience. The provider is an internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation. DR. William N. Bichai, M.D. NPI is 1548349004. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

15202 THUNDER VALLEY RD
BAKERSFIELD, CA
ZIP 93314-222
Phone: (661) 327-8000
Fax: (661) 327-8020

The NPI 1548349004 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Dialysis services, 4 or more physician visits per month (20 years or older) (HCPCS:90960)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Injection, cefepime hydrochloride, 500 mg (HCPCS:J0692)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Injection, sotrovimab, 500 mg (HCPCS:Q0247)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency (HCPCS:M0223)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; first dose (HCPCS:0001A)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency (HCPCS:M0223)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Injection, casirivimab and imdevimab, 1200 mg (HCPCS:Q0244)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Injection of drug or substance into vein (HCPCS:96374)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)

The enumeration date for this NPI number is 11/3/2006 and was last updated on 9/28/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: